Posts

Showing posts with the label Chantix

Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content | FDA

Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content | FDA : Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable intake limit. As alternative suppliers have been approved in the United States, Pfizer

FDA Alert: Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of Chantix (Varenicline) Tablets Due to N-Nitroso Varenicline Content

FDA Alert: Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of Chantix (Varenicline) Tablets Due to N-Nitroso Varenicline Content

FDA alerts health care professionals and patients to a voluntary recall of varenicline (Chantix) to the warehouse level | FDA

FDA alerts health care professionals and patients to a voluntary recall of varenicline (Chantix) to the warehouse level | FDA : FDA alerts health care professionals and patients to a voluntary recall of varenicline (Chantix) to the warehouse level.

FDA Alert: FDA Alerts Health Care Professionals and Patients to a Voluntary Recall of Chantix (varenicline) to the Warehouse Level

FDA Alert: FDA Alerts Health Care Professionals and Patients to a Voluntary Recall of Chantix (varenicline) to the Warehouse Level